Orlando L. Rivero, MDJune 8, 2023

FDA 483 - Orlando L. Rivero, MD - June 08, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Orlando L. Rivero, MD

Record Details

An FDA inspection of Orlando L. Rivero, MD, a clinical investigator in Miami, revealed two significant observations related to the conduct of a clinical study. The firm failed to obtain proper informed consent for one subject and did not conduct the investigation in accordance with the investigational plan, specifically regarding access to unblinded records. These issues indicate deficiencies in human subject protection and adherence to study protocols.

Company: Orlando L. Rivero, MD
Inspection Date: June 8, 2023
Product Type: Drugs
Office: Office of Medical Device and Radiological Health Division II
Person: Emily A. Baldwin (investigator)

Open in Dashboard

ID · de077aa5-f36c-447a-a85a-66b7ffa53adc